Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The proteasome is a major autoantigen in multiple sclerosis.

Mayo I, Arribas J, Villoslada P, Alvarez DoForno R, Rodríguez-Vilariño S, Montalban X, De Sagarra MR, Castaño JG.

Brain. 2002 Dec;125(Pt 12):2658-67.

PMID:
12429593
2.

Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type.

Feist E, Kuckelkorn U, Dörner T, Dönitz H, Scheffler S, Hiepe F, Kloetzel PM, Burmester GR.

Arthritis Rheum. 1999 Apr;42(4):697-702.

3.

Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus.

Feist E, Dörner T, Kuckelkorn U, Schmidtke G, Micheel B, Hiepe F, Burmester GR, Kloetzel PM.

J Exp Med. 1996 Oct 1;184(4):1313-8.

4.

Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis.

Mayo I, Arizti P, Parés A, Oliva J, Doforno RA, de Sagarra MR, Rodés J, Castaño JG.

J Hepatol. 2000 Oct;33(4):528-36.

PMID:
11059856
5.

Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i).

Scheffler S, Kuckelkorn U, Egerer K, Dörner T, Reiter K, Soza A, Burmester GR, Feist E.

Rheumatology (Oxford). 2008 May;47(5):622-6. doi: 10.1093/rheumatology/ken042. Epub 2008 Mar 27.

PMID:
18375405
6.

Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.

Egerer K, Kuckelkorn U, Rudolph PE, Rückert JC, Dörner T, Burmester GR, Kloetzel PM, Feist E.

J Rheumatol. 2002 Oct;29(10):2045-52.

PMID:
12375310
7.

Autoimmune response to proteasome activator 28alpha in patients with connective tissue diseases.

Matsushita M, Takasaki Y, Takeuchi K, Yamada H, Matsudaira R, Hashimoto H.

J Rheumatol. 2004 Feb;31(2):252-9.

PMID:
14760793
8.

Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.

Delunardo F, Conti F, Margutti P, Alessandri C, Priori R, Siracusano A, Riganò R, Profumo E, Valesini G, Sorice M, Ortona E.

Arthritis Res Ther. 2006;8(3):R71. Epub 2006 Apr 12.

9.
10.

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.

Lily O, Palace J, Vincent A.

Brain. 2004 Feb;127(Pt 2):269-79. Epub 2003 Dec 8.

PMID:
14662514
11.

Autoantibodies to low-density-lipoprotein-receptor-related protein 2 (LRP2) in systemic autoimmune diseases.

Ooka S, Matsui T, Nishioka K, Kato T.

Arthritis Res Ther. 2003;5(3):R174-80. Epub 2003 Apr 4.

12.

Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma.

Dutaud D, Aubry L, Henry L, Levieux D, Hendil KB, Kuehn L, Bureau JP, Ouali A.

J Immunol Methods. 2002 Feb 1;260(1-2):183-93.

PMID:
11792388
13.

Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.

Beyer NH, Milthers J, Bonde Lauridsen AM, Houen G, Lautrup Frederiksen J.

Scand J Clin Lab Invest. 2007;67(7):696-706.

PMID:
17852796
14.

Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus.

Arribas J, Luz Rodríguez M, Alvarez-Do Forno R, Castaño JG.

J Exp Med. 1991 Feb 1;173(2):423-7.

15.

Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.

Krause S, Kuckelkorn U, Dörner T, Burmester GR, Feist E, Kloetzel PM.

Ann Rheum Dis. 2006 Aug;65(8):1021-7. Epub 2006 Jan 13.

16.

Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.

Laplaud DA, Ruiz C, Wiertlewski S, Brouard S, Berthelot L, Guillet M, Melchior B, Degauque N, Edan G, Brachet P, Damier P, Soulillou JP.

Brain. 2004 May;127(Pt 5):981-95. Epub 2004 Feb 25.

PMID:
14985265
18.

A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.

Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.

Arthritis Rheum. 2006 Dec;54(12):3939-44.

19.

Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool.

Lefranc D, Almeras L, Dubucquoi S, de Seze J, Vermersch P, Prin L.

J Immunol. 2004 Jan 1;172(1):669-78.

20.

Diagnostic importance of anti-proteasome antibodies.

Feist E, Dörner T, Kuckelkorn U, Scheffler S, Burmester G, Kloetzel P.

Int Arch Allergy Immunol. 2000 Sep;123(1):92-7. Review.

PMID:
11014975

Supplemental Content

Support Center